135 related articles for article (PubMed ID: 33928124)
1. Corrigendum: Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-Small-Cell Lung Cancer.
Gan J; Meng Q; Li Y
Front Mol Biosci; 2021; 8():653454. PubMed ID: 33928124
[TBL] [Abstract][Full Text] [Related]
2. Systematic Analysis of Expression Profiles and Prognostic Significance for
Gan J; Li Y; Meng Q
Front Mol Biosci; 2020; 7():572406. PubMed ID: 33363204
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer.
Zhang T; Lai S; Cai Y; Huang Z; Li Y; Chen S; Zhang Z; Ye Z; Lai X; Zhai E; Cai S; Chen J
Front Cell Dev Biol; 2021; 9():719613. PubMed ID: 34869310
[No Abstract] [Full Text] [Related]
4. Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma.
Ma Z; Zhou Z; Zhuang H; Li Z; Ma Z; Huang B; Liu C; Gong Y; Zou Y; Zheng Z; Huang S; Zhang C; Hou B
Dis Markers; 2021; 2021():6682697. PubMed ID: 33747255
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.
Zhang X; He X; Li Y; Xu Y; Chen W; Liu X; Hu X; Xiong L; Xu X
Front Mol Biosci; 2021; 8():826905. PubMed ID: 35004862
[TBL] [Abstract][Full Text] [Related]
6. Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review.
Jiang Y; Yu J; Zhu T; Bu J; Hu Y; Liu Y; Zhu X; Gu X
J Cancer; 2023; 14(10):1888-1903. PubMed ID: 37476189
[TBL] [Abstract][Full Text] [Related]
7. FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach.
Snijders AM; Lee SY; Hang B; Hao W; Bissell MJ; Mao JH
Mol Oncol; 2017 Feb; 11(2):167-179. PubMed ID: 28078827
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Identification of circRNA biomarker for gastric cancer through integrated analysis.
Hossain MT; Li S; Reza MS; Feng S; Zhang X; Jin Z; Wei Y; Peng Y
Front Mol Biosci; 2023; 10():1249019. PubMed ID: 37469706
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: Comprehensive analysis of the potential immune-related biomarker transporter associated with antigen processing 1 that inhibits metastasis and invasion of ovarian cancer cells.
Li X; Zeng S; Ding Y; Nie Y; Yang M
Front Mol Biosci; 2022; 9():984209. PubMed ID: 36120547
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Systematic analysis of MCM3 in pediatric medulloblastoma
Cao L; Zhao Y; Liang Z; Yang J; Wang J; Tian S; Wang Q; Wang B; Zhao H; Jiang F; Ma J
Front Mol Biosci; 2022; 9():1076243. PubMed ID: 36452454
[TBL] [Abstract][Full Text] [Related]
11. FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance.
Bartel CA; Parameswaran N; Cipriano R; Jackson MW
Oncotarget; 2016 Aug; 7(32):52597-52612. PubMed ID: 27221039
[TBL] [Abstract][Full Text] [Related]
12. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer.
Cipriano R; Miskimen KL; Bryson BL; Foy CR; Bartel CA; Jackson MW
Mol Cancer Res; 2014 Aug; 12(8):1156-65. PubMed ID: 24736947
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: The Immune System in Transfusion-Related Acute Lung Injury Prevention and Therapy: Update and Perspective.
Guo K; Ma S
Front Mol Biosci; 2021; 8():720653. PubMed ID: 34513926
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.
Li X; Qiu N; Li Q
Front Genet; 2021; 12():838600. PubMed ID: 35145547
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Prognostic values and clinical significance of S100 family member's individualized mRNA expression in pancreatic adenocarcinoma.
Li X; Qiu N; Li Q
Front Genet; 2022; 13():1057431. PubMed ID: 36338965
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Corrigendum: Prognostic values and clinical significance of S100 family member's individualized mRNA expression in pancreatic adenocarcinoma.
Frontiers Production Office
Front Genet; 2022; 13():1089027. PubMed ID: 36468016
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Predicting Outcomes From Radical Radiotherapy for Non-small Cell Lung Cancer: A Systematic Review of the Existing Literature.
Walls GM; Hanna GG; Qi F; Zhao S; Xia J; Ansari MT; Landau D
Front Oncol; 2019; 9():112. PubMed ID: 30881918
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Identification and Characterization of Thermostable Y-Family DNA Polymerases η, ι, κ and Rev1 From a Lower Eukaryote,
Vaisman A; McDonald JP; Smith MR; Aspelund SL; Evans TC; Woodgate R
Front Mol Biosci; 2021; 8():819157. PubMed ID: 34977160
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Transcription factors BARX1 and DLX4 contribute to progression of clear cell renal cell carcinoma
Sun G; Ge Y; Zhang Y; Yan L; Wu X; Ouyang W; Wang Z; Ding B; Zhang Y; Long G; Liu M; Shi R; Zhou H; Chen Z; Ye Z
Front Mol Biosci; 2022; 9():1026319. PubMed ID: 36406262
[TBL] [Abstract][Full Text] [Related]
20. The FAM83 family of proteins: from pseudo-PLDs to anchors for CK1 isoforms.
Bozatzi P; Sapkota GP
Biochem Soc Trans; 2018 Jun; 46(3):761-771. PubMed ID: 29871876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
